Disney’s Boardroom Battle: Small Shareholders vs. Hedge Funds

Orlando, Florida – The battle over the control of Disney’s board of directors continues to intensify as small shareholders and hedge funds clash in a struggle for influence. As T. Rowe Price throws its support behind Disney’s current directors, led by CEO Bob Chapek, the tension escalates with Nelson Peltz, an activist investor seeking change within the company. Peltz, known for his aggressive approach in corporate battles, has been pushing for a more significant role …

Read more

Negotiations with Pharmaceutical Companies Offer Reassuring Lip Service to Shareholders, Advocates Say

Los Angeles, California – Pharmaceutical companies are facing scrutiny over their responses to negotiations with the Centers for Medicare and Medicaid Services (CMS) regarding drug prices. AstraZeneca CEO Pascal Soriot described the initial offer as “relatively encouraging,” while Pfizer CFO David Denton downplayed the impact on investors, calling it “modest.” Advocates, however, view these statements as mere lip service to calm shareholders rather than a genuine commitment to lowering drug prices. Merith Basey, executive director …

Read more